JACQUELINE FRYE: Open Payments
NPI 1396254447 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,947 in 78 payments from 18 companies in 2025. Trend: 2023 $1,398 · 2024 $1,234 · 2025 $1,947
Food & beverage: $1,683Education: $264
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $498 |
| Sumitomo Pharma America, Inc. | 14 | $258 |
| Astellas Pharma US Inc | 5 | $216 |
| ABBVIE INC. | 9 | $174 |
| Dendreon Pharmaceuticals LLC | 8 | $137 |
| Janssen Scientific Affairs, LLC | 1 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $99 |
| Olympus America Inc. | 5 | $85 |
| PFIZER INC. | 5 | $81 |
| Merck Sharp & Dohme LLC | 4 | $67 |
Products named: ERLEADA, GEMTESA, BOTOX, PROVENGE, XTANDI, RYBREVANT, iTIND System, Nubeqa.
Industry payments across LA — which companies pay providers there.
